Ignite Creation Date:
2024-05-06 @ 10:18 AM
Last Modification Date:
2024-10-26 @ 12:28 PM
Study NCT ID:
NCT03223376
Status:
UNKNOWN
Last Update Posted:
2022-09-02
First Post:
2017-07-18
Brief Title:
A Phase III Study of Fruquintinib in Combination With Paclitaxel in Second Line Gastric CancerFRUTIGA
Sponsor:
Hutchison Medipharma Limited
Organization:
Hutchmed
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-18
Start Date Type:
ACTUAL
Primary Completion Date:
2022-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2022-11
Completion Date Type:
ESTIMATED
First Submit Date:
2017-07-18
First Submit QC Date:
July 18 2017
Study First Post Date:
2017-07-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-08-31
Last Update Post Date:
2022-09-02
Last Update Post Date Type:
ACTUAL